The global enteral nutrition market size was valued at USD 8,182 million in 2021, which is envisioned to grow at a CAGR of 7.4% and reach USD 14,485 million during the forecast period.
Enteral nutrition is recommended for patients who cannot consume enough nutrients orally but whose gastrointestinal function is adequate for digestion and absorption. The enteral nutrition procedure is implemented when a patient cannot eat due to an illness, has difficulty swallowing, or has undergone surgery that could interfere with the normal eating process. Enteral nutrition is administered directly to the patient's stomach, duodenum, or jejunum using enteral pumps and feeding tubes. Patients suffering from chronic illnesses like malnutrition, gastrointestinal disorders, cancer, and others may be prescribed enteral nutrients as part of their treatment.
The primary factor contributing to the expansion of the enteral nutrition market is the increasing incidence of diseases like cancer and neurological disorders. In addition to the increase in the geriatric population and a rise in malnutrition cases, additional factors are driving the market's expansion. Because of improvements in techniques, configurations, and ingredients, enteral nutrition is gaining popularity over time. However, the lack of demand and awareness of enteral nutrition in developing nations hinders market growth. On the other hand, introducing innovative and technologically advanced products and the high market potential in unutilized emerging economies are anticipated to create lucrative growth opportunities for the enteral nutrition market.
|Market Size||USD 14,485 million|
|Fastest Growing Market||Europe|
|Largest Market||North America|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
Growing Cases of Chronic Diseases and Geriatric Population
Patients unable to swallow or consume enough nutrients orally are prescribed enteral nutrition. People with various chronic conditions, including cancer, neurological disorders, gastrointestinal disorders, malnutrition, and diabetes, cannot swallow or ingest food. Consequently, the demand for enteral nutrition will be fueled by the rise in chronic disease cases. After a person develops a chronic illness, his or her nutritional requirements alter. In addition, enteral nutrition includes diabetes-specific formulas with a specific nutrient composition designed to help diabetic patients manage their blood glucose levels. Thus, a rise in chronic diseases will propel the global enteral nutrition market share during the forecast period.
The growing geriatric population is another factor. The percentage of the world's population of 60 years old is expected to nearly double between 2015 and 2050 from 12% to 22%, according to estimates from the World Health Organization in 2018. As the aging population becomes less capable of ingesting solid food particles, this statistic is anticipated to increase the demand for enteral nutrition-related products. As a result of decreased immunity and degeneration, the elderly population is relatively susceptible to various diseases, which is another primary market driver for enteral nutrition. Sickness is common among the elderly, and their recovery and treatment are slow. Consequently, they consume a more significant proportion of health services than other patients. The senior population has increased substantially globally and is susceptible to various diseases, including cardiovascular, stroke, diabetes, gastric, and intestinal disorders.
Lower Demand in Under-Developing Nations
In developing nations such as Asia and Africa, a lack of financial resources, a low income, a smaller number of nutritional product companies, and the absence of advanced manufacturing systems impede the enteral nutrition market growth In addition, insufficient government support for the adaptation of enteral nutrition products and a lack of trained professionals inhibits the growth of the enteral nutrition market in developing nations like Ethiopia, Afghanistan, and Guinea.
Market in Emerging Economies
The developing markets of Asia-Pacific and LAMEA present lucrative growth opportunities for the enteral nutrition industry due to the improvement of the healthcare system in these regions and the rise in patient demand for better healthcare services. The increase in chronic disease prevalence in developing nations fuels the demand for enteral nutrition. In addition, rising healthcare expenditures in these regions are anticipated to drive enteral protein market expansion.
The region-wise segmentation of the global enteral nutrition market includes North America, Europe, Asia-Pacific, and LAMEA.
North America will command the market with the largest share during the forecast period growing at a CAGR of 6.6%. The region's leading position is attributable to its well-developed healthcare industry, the presence of enteral nutrition manufacturers, and the increase in the number of patients treated at home. In addition, an increase in the use of enteral nutritional products and the number of patients treated in the region contribute to the market's expansion. The growing incidence of chronic diseases in North America has increased the demand for enteral nutrition in the region. In 2018, 10.5% of the U.S. population, or approximately 34.2 million people of all ages, were diagnosed with diabetes, as reported by the Centers for Disease Control and Prevention (CDC). Additionally, it is anticipated that the presence of key players in North America will boost the region's growth by generating more revenue.
Europe will hold a share of USD 4,612c million, growing at a CAGR of 7.3% during the forecast period. The market for enteral nutrition in Europe is anticipated to expand at a moderate rate over the forecast period because of the rising prevalence of chronic diseases and the swift incorporation of enteral nutritional therapies in the region. The uptick in the geriatric population that requires enteral nutrition products to live a higher quality of life contributes to the industry's increased revenue over the forecast period. In 2019, the United Kingdom was one of the major nations in the European enteral nutritional market, with a geriatric population of approximately 12 million individuals aged 65 and older.
The market for enteral nutrition in Germany is growing steadily due to factors such as an increase in cancer, neurological disorders, and gastrointestinal disorders, as well as an increase in the geriatric population as the healthcare industry advances and life expectancy rises. Moreover, according to the European Brain Council, approximately 220.7 million Europeans were affected by at least one neurological disease in 2018.
The global enteral nutrition market is bifurcated based on protein composition, form, age group, distribution channel, and region.
The segments include:
The segment of the standard protein diet will hold the largest share during the forecast period growing at a CAGR of 7.3%. Obese individuals adhere to the standard protein-based diet. It can also aid in weight management when combined with a healthy diet. It improves health because the protein aids in tissue maintenance and repair. Moreover, the standard protein diet helps the body to boost its metabolism and aids individuals in calorie burning. It can suppress appetite, increase satiety, and assist obese patients in losing weight. It is known that different product launches of standard protein-rich products satisfy market demand. In addition, there has been a sharp increase in the number of products derived from organic products, leading to an increase in the demand for standard protein diets.
The high protein supplement segment will hold the second-largest share. Increased product launches by manufacturers in response to increased demand for high-protein supplements are expected to augment the market of this segment. The campaigns carried out by the ambassadors for high-protein supplements have attracted the general public's attention, thereby boosting market demand. An increase in patients requiring high-protein supplements is anticipated to drive market expansion. In addition, catabolic patients and those diagnosed with severe malnutrition rely on protein-rich supplements.
Based on form, the segments include powder and liquid.
The liquid segment is anticipated to hold the largest market share growing at a CAGR of 7.8% during the forecast period. The liquid form of enteral nutrition is a ready-to-use or instant nutrition formula available in prefilled, ready-to-hang containers and specially designed cans for tube feeding. Before being boosted or pierced with a feeding set, these packages can be kept at room temperature. The rapid absorption of the formula to the gastric walls, resulting in a quicker metabolic rate, is one of the significant benefits of taking these products in liquid form. Tube-fed patients prefer the liquid form of enteral nutrition due to its rapid results.
The powder form of enteral nutrition is a form of packaging in which solid enteral formulae are contained. The powders are now offered in various flavors and hues to increase suitability. In contrast to the liquid form, powders' consumption quantity can be specified. In addition, the powdered form of enteral nutrition has a longer shelf life, increasing its popularity compared to the other forms.
Based on the age group, the segments include adults (above 18 years) and pediatrics (below 18 years).
The segment of adults (above 18) is most likely to hold the largest market share during the forecast period growing at a CAGR of 7.1%. Adults over 18 who suffer from swallowing disorders, throat cancer, gastrointestinal disorders, diabetes, and other conditions require enteral nutrition. They can thrive well on tube feeding for as long as required. Furthermore, malnourished adults must receive enteral nutrition. Patients with a body mass index of <20 are considered chronically ill and typically suffer from cancer, gastrointestinal diseases, respiratory issues, and neurological or psychiatric disorders. These patients are at high risk for malnutrition. This factor stimulates the expansion of the market for adult enteral nutrition.
Patients under the age of 18 require special care and have numerous requirements for proper growth and development. Children with maldigestion and malabsorption who cannot consume enough food should receive enteral nutrition (nutritional losses). Children under the age of 18 who struggle from bowel syndrome, chronic diarrhea of infancy, Crohn's disease, inborn errors, organ dysfunction, and other conditions require pediatric enteral nutrition products.
Based on the distribution channel, the segments are hospital sales, retail, and online.
The segment of hospital sales is most likely to hold the largest share during the forecast period growing at a CAGR of 7.2%. A wider variety of medications, including general, specialized, and investigational medications, are available at the pharmacies of multiple hospitals. Some pharmacies allow the use of over-the-counter (OTC) medications and supplements outside of hospital grounds. These pharmacies are the places where enteral nutrition products can be obtained. The percentage of enteral formulae accessible for use has increased significantly over the years due to excellent health and nutrition awareness, cost-effectiveness, and market accessibility of enteral nutrition products.
The retail segment will hold the second-largest share. A retail pharmacy provides general healthcare and sells prescription and non-prescription medications to the general public. Unlike hospital pharmacies, retail pharmacies typically do not sell investigational medications and operate in a retail environment. However, the network of retail pharmacies is greater than that of other distribution channels, as they are available in most cities and streets and easily accessible to individuals. The location is closest to the patient's homes and those who must distribute the product, so it is considered the most accessible option.